Recent studies show that FOXO1 promotes inflammation during diabetes by enhancing TLR4-mediated signaling, suggesting FOXO1 as a key mediator of inflammatory responses during obesity and diabetes [49]. Here, FOXO1 is linked to obesity disorder.